You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Here you'll find rankings, projections, cheat sheets, analysis and strategy. Check back every day for new content through Opening Day of the 2025 season. If this is your first time playing fantasy ...

navi allows you to browse through cheatsheets (that you may write yourself or download from maintainers) and execute commands. Suggested values for arguments are dynamically displayed in a list.

ImmunityBio (IBRX) is jumping 20% after the drug maker reported that the FDA had approved its use of an "alternative source of BCG." Specifically, the company will now be able to provide this ...

CULVER CITY, Calif., February 19, 2025--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has ...

ImmunityBio (IBRX) announced the U.S. Food and Drug Administration FDA has authorized an expanded access program EAP that will bring a vital alternative source of BCG, a standard-of-care medicine ...

FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication. The FDA has approved an expanded access program that will provide an alternative ...

With Merck & Co. largely propping up supplies of the bladder cancer-fighting bacteria Bacillus Calmette-Guérin (BCG) in the U.S., ImmunityBio has received the FDA all-clear to help pick up the ...